EICHORCondition: Musculoskeletal Inflammation · Exercise-Induced Muscle Damage · Post-Exercise Recovery · Sponsor: Parlay Wellness
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will evaluate the effects of Parlay Recover peptide gummies (containing Body Protection Compound BPC-157) on markers of inflammation, physical performance, and recovery in physically active adults. Over an 8-week period, 40 participants will consume two gummies daily and complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, as well as undergo blood testing at Baseline and Week 8. The primary objective is to examine changes in inflammatory biomarkers (hs-CRP and IL-6) as measured by blood testing. Secondary objectives include evaluating participants' self-reported perceptions of the product's effects on physical performance and recovery, including aching, stiffness, function, and recovery of muscles and joints.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Be male or female. * Be aged 18-65. * Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, over the past 3 months (e.g., running, gym/strength training, cycling, team sports, fitness classes). * Within the last 4 weeks, reports post-exercise musculoskeletal symptoms (aching, stiffness, or delayed recovery) at least once per week. * Willing to maintain current exercise routine throughout the 8-week study (no major changes in frequency, intensity, or new training programs). * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * If taking products or supplements that target muscle and joint health, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration. * Willing to maintain the same diet and sleep schedule throughout the study duration. * Resides in the United States. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Use of specialized recovery modalities (e.g., cryotherapy, frequent sports massage, IV nutrition, high-dose recovery supplements) started within the past 8 weeks or expected to be initiated during the trial. * Acute illness or infection within 14 days prior to Baseline (e.g., fever, flu, COVID-19) or planned surgery during the study. * History of inflammatory or autoimmune conditions, including but not limited to rheumatoid arthritis, lupus, inflammatory bowel disease (IBD), ankylosing spondylitis, Hashimoto's thyroiditis, or Grave's disease. * Use of systemic corticosteroids (such as prednisone) within past 8 weeks. * Recent intra-articular steroid injection within 12 weeks. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Anyone who is a heavy drinker (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone with uncontrolled chronic diseases, including but not limited to hypertension (high blood pressure) and diabetes. * Anyone unwilling to follow the study protocol. * Anyone with nut sensitivity or allergy. * Anyone with a history of substance abuse. * Musculoskeletal injury within the past 8 weeks that required any type of modification in your exercise routine. * Planning on introducing any new products, prescription medications, or supplements that target muscle health, joint health, or exercise performance for the study duration. * Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration. * Anyone with a history of hypotension. * Anyone who is currently taking antihypertensive medication.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Citruslabs | Las Vegas, Nevada, United States | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07752381